𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy of combination therapy of interferon-α with ursodeoxycholic acid in chronic hepatitis C: A randomized controlled clinical trial

✍ Scribed by Shinichi Kiso; Sumio Kawata; Shinji Tamura; Yasuharu Imai; Yoshiaki Inui; Toshihiko Nagase; Yuichi Maeda; Eiji Yamasaki; Hirofumi Tsushima; Takumi Igura; Seiichi Himeno; Kouichi Seki; Yuji Matsuzawa

Publisher
Springer Japan
Year
1997
Tongue
English
Weight
694 KB
Volume
32
Category
Article
ISSN
0944-1174

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interferon and ursodeoxycholic acid comb
Interferon and ursodeoxycholic acid combined therapy in the treatmet of chronic viral C hepatitis: Results from a controlled randomized trial in 80 patients
✍ Eveline Boucher; Hervé Jouanolle; Patrice Andre; Annick Ruffault; Dominique Guya 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 744 KB

Because 70% to 75% of patients with chronic hepatitis C either do not respond to or relapse after interferon (IFN) therapy, and because ursodeoxycholic acid (UDCA) has been shown to reduce aminotransferase lev-TOLOGY 199% 21 :322-327.

Interferon-α and zidovudine combination
Interferon-α and zidovudine combination therapy for chronic hepatitis B: Results of a randomized, placebo-controlled trial
✍ Harry L. A. Janssen; Luuk Berk; Rudolf A. Heijtink; Fiebo J. W. Ten Kate; Solko 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 630 KB

Interferon-a therapy leads to HBeAg seroconversion in only one third of patients with chronic hepatitis B. In an attempt to increase the seroconversion rate, we investigated the combination of interferon-a and zidovudine in a subset of patients with presumably low response rates for interferon-a mon

A randomized controlled trial of high-do
A randomized controlled trial of high-dose maintenance interferon therapy in chronic hepatitis C
✍ Di Marco, Vito; Lo Iacono, Oreste; Cammà, Calogero; Almasio, Piero L.; Vaccaro, 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 2 views

In chronic hepatitis C virus (HCV) infection, the rate of sustained response to interferon is low. We evaluated, in patients responding to a 26-week course of interferon, the effect of high-dose maintenance therapy in preventing relapse. Three hundred and ten patients with chronic HCV infection (38.

Treatment of chronic hepatitis C with re
Treatment of chronic hepatitis C with recombinant human interferon-α2a: Results of a randomized controlled clinical trial
✍ Giulio Diodati; Paola Bonetti; Franco Noventa; Carla Casarin; Massimo Rugge; Ser 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 506 KB

Sixty consecutive patients with chronic hepatitis C were included in a randomized controlled trial of recombinant human interferon-%, vs. no treatment. Treated patients received tapering doses of interferon thrice weekly for 1 yr. Twenty treated cases (66.7%) normalized serum aminotransferase levels

Prospective, randomized controlled trial
Prospective, randomized controlled trial of interferon-α in children with chronic hepatitis B
✍ Mercedes Ruiz-Moreno; Maria José Rua; Josefina Molina; Gloria Moraleda; Alberto 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 522 KB

Thirty-six children with chronic hepatitis B were entered into a randomized controlled trial of recombinant human interferon-a. All patients had hepatitis B virus DNA and increased levels of aminotransferases in serum for at least 1 yr. Twelve children received 10 MU of interferon-a 2b/m2 body surfa

Treatment of chronic hepatitis C with co
Treatment of chronic hepatitis C with consensus interferon: A multicenter, randomized, controlled trial
✍ M J Tong; K R Reddy; W M Lee; P J Pockros; J C Hoefs; E B Keeffe; F B Hollinger; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 222 KB 👁 2 views

AND THE CONSENSUS INTERFERON STUDY GROUP 15 tion. Efficacy was assessed by normalization of serum alanine This multicenter, randomized, controlled, double-blind, transaminase (ALT) concentration and decrease in serum hepphase III study in 704 patients with chronic hepatitis C infecatitis C virus (HC